Gas-promoted in situ bioadhesive foam platform for efficient macromolecule delivery in the treatment of inflammatory bowel disease

Promotor: Prof. Ana Beloqui

Related publications :
•    Zhang W., Van den Bossche W., Yagoubi H., Kambale E.K., Whani K., Saxena T., Guilbaud L., Moreels T.G., Messens J., Beloqui A. Glepaglutide-loaded foam for the induction of mucosal healing in the treatment of inflammatory bowel disease. Advanced Healthcare Materials (2025) Accepted.
•    Zhang W., McCartney F., Xu Y., Bohns Michalowski C., Domingues I., Kambale E.K., Moreels T.G., Guilbaud L., Chen C., Marotti V., Brayden D.J., Beloqui A. An in situ bioadhesive foam as a large intestinal delivery platform for antibody fragment to treat inflammatory bowel disease. Journal of Controlled Release 374 (2024) 254-266.
•    Zhang W., Bohns Michalowski C., Beloqui A. Oral delivery of biologics in inflammatory bowel disease treatment. Frontiers in Bioengineering and Biotechnology Nanobiotechnology 9 (2021) 675194

Info: ana.beloqui@uclouvain.be

Friday January 31, 2025 – 4pm – Auditoire Maisin